3'-Selenobisalanine" No Further a Mystery
These trials showed clinically sizeable pharmacokinetic interactions [seven] characterised by a minimize within the clearance on the anticancer drug and for this reason elevated exposure. The interpretation of subsequent section II and III scientific trials was complicated as it was impossible to administer exactly the same dose of chemotherapy ins